scholarly article | Q13442814 |
P50 | author | Matthias Egger | Q19996372 |
Andrew Boulle | Q53680127 | ||
François Dabis | Q56850448 | ||
Paula Braitstein | Q83393911 | ||
Eric Balestre | Q117285335 | ||
P2093 | author name string | Mauro Schechter | |
Eduardo Sprinz | |||
James McIntyre | |||
Martin Schneider | |||
David Bangsberg | |||
Paolo Miotti | |||
Christian Laurent | |||
Catherine Seyler | |||
Gorana Capkun | |||
Antiviral Therpapy in Lower Income Countries (ART-LINC) Study Group | |||
Charles Kabugo | |||
Stefan Van der Borght | |||
W G Martin Brinkhof | |||
P433 | issue | 5 | |
P921 | main subject | anti-retroviral agent | Q50430310 |
collaboration | Q1145523 | ||
P304 | page(s) | 979-986 | |
P577 | publication date | 2005-09-12 | |
P1433 | published in | International Journal of Epidemiology | Q6051393 |
P1476 | title | Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts | |
P478 | volume | 34 |
Q37043399 | Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy |
Q37043395 | Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America |
Q38452995 | Brazilian psychosocial and operational research vis-à-vis the UNGASS targets |
Q34718675 | Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Colla |
Q37143745 | Children and HIV/AIDS: from research to policy and action in resource-limited settings |
Q35945152 | Choice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study. |
Q36628019 | Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy |
Q36936569 | Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme |
Q40665399 | Cohort Profile: The Khayelitsha antiretroviral programme, Cape Town, South Africa. |
Q38880585 | Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration |
Q36273986 | Community-based ART distribution system can effectively facilitate long-term program retention and low-rates of death and virologic failure in rural Uganda |
Q33777533 | Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. |
Q33803701 | Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa |
Q28476337 | Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal |
Q46172422 | Database-supported teleconferencing: an additional clinical mentoring tool to assist a multinational company HIV/AIDS treatment program in Africa |
Q36941573 | Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies |
Q37108925 | Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries |
Q33399742 | Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings |
Q36440576 | Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy |
Q33750295 | Evaluation of three sampling methods to monitor outcomes of antiretroviral treatment programmes in low- and middle-income countries |
Q42247975 | Four years of experience with antiretroviral therapy in adult patients in Karachi, Sindh, Pakistan. |
Q34735495 | HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City |
Q34769839 | High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia |
Q35074204 | High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo |
Q34604679 | Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria |
Q56786182 | Long-Term Outcomes of a National Expanded Access Program to Antiretroviral Therapy: The Chilean AIDS Cohort |
Q37477423 | Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies |
Q46709465 | Lopinavir/ritonavir monotherapy as maintenance treatment in HIV-infected individuals with virological suppression: results from a pilot study in Brazil |
Q34320076 | Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings |
Q34228301 | Measuring the quality of observational study data in an international HIV research network |
Q33862806 | Mortality after failure of antiretroviral therapy in sub-Saharan Africa |
Q38851677 | Mortality and survival patterns of people living with HIV-2 |
Q33574798 | Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings |
Q46391119 | Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries |
Q56530532 | Mortality of HIV-infected patients in low-income countries – Authors’ response |
Q82029714 | Neuroepidemiology of HIV/AIDS |
Q35910240 | No differences in clinical outcomes with the addition of viral load testing to CD4 cell count monitoring among HIV infected participants receiving ART in rural Uganda: Long-term results from the Home Based AIDS Care Project |
Q58265885 | Prevalence and risk factors associated with syphilis in a cohort of HIV positive individuals in Brazil |
Q33926747 | Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings |
Q33798752 | Quality of data collection in a large HIV observational clinic database in sub-Saharan Africa: implications for clinical research and audit of care |
Q30363938 | Responding to the HIV pandemic: the power of an academic medical partnership. |
Q33388709 | Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya |
Q51809092 | Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. |
Q38378260 | Shifting the HIV Training and Research Paradigm to Address Disparities in HIV Outcomes |
Q34208678 | Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring |
Q37357222 | Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil |
Q36628346 | The cost-effectiveness of antiretroviral therapy for treating HIV disease in the Caribbean |
Q36942918 | Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries |
Q35117177 | Tuberculosis in HIV programmes in lower-income countries: practices and risk factors |
Q34062163 | Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America |
Q34556999 | Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic |
Search more.